Tuesday, June 15, 2021
President & CEO
Unmet Medical Needs in SMA
Jill Jarecki, Ph.D.
Chief Scientific Officer, Cure SMA
Apitegromab TOPAZ Phase 2 Data and Phase 3 Trial Design Considerations
Yung Chyung, M.D.
Chief Medical Officer
Panel Discussion on Apitegromab’s Therapeutic Potential in SMA
Thomas Crawford, M.D. and Basil Darras, M.D.
Moderated by Yung Chyung, M.D.